[
    {
        "file_name": "CERES,INC_01_25_2012-EX-10.20-CollaborationAgreement.txt",
        "perturbation": [
            {
                "type": "Ambiguities - In Text Contradiction",
                "original_text": "4.1 \"JOINT INTELLECTUAL PROPERTY\" shall mean (a) all patentable inventions conceived, discovered, developed and/or reduced to practice (i)  jointly by one or more employees, agents, or students of CERES and by one or more employees, agents, or students of IGER in the performance of  any RESEARCH PROJECT(S) or (ii) by one or more employees, agents or students of IGER in the performance of any RESEARCH PROJECT(S) to  the extent CERES provides a financial contribution for such RESEARCH PROJECT, which is not less than twenty-five percent (25%) of either the  overall cost of such RESEARCH PROJECT or of the activity during which the invention was made, unless expressly provided otherwise in a  SCHEDULE; (b) patents, patent applications, plant variety rights, plant variety right applications, reissues, continuations, continuations-in-part  and divisionals claiming such patentable inventions in any country of the world; (c) all trade secrets and copyrighted works created jointly by one  or more employees, agents, or students of CERES and by one or more employees, agents, or students of IGER in the performance of any  RESEARCH PROJECT(S); and (d) all germplasm and plant varieties created in the performance of plant breeding activities in the performance of  any RESEARCH PROJECT(S).",
                "changed_text": "4.1 \"JOINT INTELLECTUAL PROPERTY\" shall mean (a) all patentable inventions conceived, discovered, developed and/or reduced to practice (i)  jointly by one or more employees, agents, or students of CERES and by one or more employees, agents, or students of IGER in the performance of  any RESEARCH PROJECT(S) or (ii) by one or more employees, agents or students of IGER in the performance of any RESEARCH PROJECT(S) to  the extent CERES provides a financial contribution for such RESEARCH PROJECT, which is not less than twenty-five percent (25%) of either the  overall cost of such RESEARCH PROJECT or of the activity during which the invention was made; (b) patents, patent applications, plant variety rights, plant variety right applications, reissues, continuations, continuations-in-part  and divisionals claiming such patentable inventions in any country of the world; (c) all trade secrets and copyrighted works created jointly by one  or more employees, agents, or students of CERES and by one or more employees, agents, or students of IGER in the performance of any  RESEARCH PROJECT(S); and (d) all germplasm and plant varieties created in the performance of plant breeding activities in the performance of  any RESEARCH PROJECT(S).",
                "explanation": "This change removes the clause \"unless expressly provided otherwise in a SCHEDULE\" from the definition of JOINT INTELLECTUAL PROPERTY. This contradicts Article 1.4, which states that SCHEDULES may contain provisions on intellectual property different from those in the main agreement, creating ambiguity about whether the definition in this section can be overridden.",
                "location": "SECTION 4"
            },
            {
                "type": "Ambiguities - In Text Contradiction",
                "original_text": "5.2.1 \"RELEASED VARIETY\" shall mean any variety of a COLLABORATION CROP which constitutes JOINT INTELLECTUAL PROPERTY and  which is released for commercialization pursuant to a SCHEDULE. IGER shall have the non-exclusive right to exploit commercially RELEASED  VARIETIES in the United Kingdom.",
                "changed_text": "5.2.1 \"RELEASED VARIETY\" shall mean any variety of a COLLABORATION CROP which constitutes JOINT INTELLECTUAL PROPERTY. IGER shall have the non-exclusive right to exploit commercially RELEASED  VARIETIES in the United Kingdom.",
                "explanation": "This edit removes the requirement for a “RELEASED VARIETY” to be ‘released for commercialization pursuant to a SCHEDULE’. However, section 5.3.1 states that if CERES proceeds to commercialise it, either in the SCHEDULE or ‘other agreements to be executed by the Parties’, there must be reasonable remuneration agreed upon. This edit would cause an in-text contradiction between sections 5.2.1 and 5.3.1.",
                "location": "SECTION 5.2"
            },
            {
                "type": "Ambiguities - In Text Contradiction",
                "original_text": "14.3 Termination of this Agreement shall not affect the rights and obligations of the Parties accrued prior to termination hereof nor any license  grants then in existence, nor either Party's non-exclusive rights to commercialize then existing RELEASED VARIETIES in the United Kingdom,  subject to payment of remuneration as set forth in any relevant license/commercialization agreements.",
                "changed_text": "14.3 Termination of this Agreement shall not affect the rights and obligations of the Parties accrued prior to termination hereof nor any license  grants then in existence, nor either Party's non-exclusive rights to commercialize then existing RELEASED VARIETIES in the United Kingdom.",
                "explanation": "This removes the clause 'subject to payment of remuneration as set forth in any relevant license/commercialization agreements'. This contradicts Article 5.3.1. by not explicitly indicating remuneration may be required.",
                "location": "SECTION 14.3"
            }
        ]
    }
]